The Full Wiki

More info on Tedisamil

Tedisamil: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
CAS number 90961-53-8
ATC code C01BD06
PubChem 65825
Chemical data
Formula C 19H32N2  
Mol. mass 288.470 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Tedisamil (planned trade name Pulzium) is an investigational class III antiarrhythmic for atrial fibrillation and atrial flutter. It is currently being developed by Solvay and is currently under regulatory review by the United States Food and Drug Administration.

On April 25, 2007, Solvay submitted a New Drug Application for tedisamil, and on December 12, 2007, the Cardio-Renal Advisory Committee of the FDA voted against approval of tedisamil, at this time, requesting that Solvay Pharmaceuticals provides additional information to the FDA.[1]


Got something to say? Make a comment.
Your name
Your email address